From October 1, 2021 to December 31, 2021, the company has repurchased 1,771,500 shares, representing 0.12% for CNY 24.24 million. With this, the company has completed the repurchase of 3,330,700 shares, representing 0.22% for CNY 45.21 million under the buyback announced on June 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.36 CNY | +3.09% | +0.20% | -9.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.75% | 3.15B | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on June 26, 2021.